Home
Par Drugs & Chemicals Ltd Share Price History
Par Drugs & Chemicals Ltd
NSE : 21 Feb, 2025
124.24-3.8 (-3.0%)
Prev Close
128.0
Open Price
121.6
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
21404
Today's High / Low
134.4 / 121.6
52 WK High / Low
348.5 / 121.6
Market Price of Par Drugs & Chemicals Ltd
1M
1Y
3Y
5Y
Monitoring Par Drugs & Chemicals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | 49 |
| Sales YoY Gr. | - |
| Adj EPS | 6.84 |
| YoY Gr. | - |
| Net Profit (Cr.) | 2 |
| BVPS | 49.83 |
Key Financial Parameters
| Parameter | 2017 |
|---|---|
| Return on Capital Emp. % | 12.3 |
| Op. Profit Mgn % | 17.43 |
| Net Profit Mgn % | 3.79 |
| Debt to Equity % | 1.52 |
Latest Shareholding
Promoters Holdings Over Time
About Par Drugs & Chemicals Ltd
- Par Drugs and Chemicals Limited was originally incorporated as a Private Limited Company with the name 'Par Drugs and Chemicals Private Limited' at Bhavnagar, Gujarat.
- On 26 February 1999.
- Subsequently, the Company was converted into a Public Limited Company and the name was changed to 'Par Drugs and Chemicals Limited' on 5 November 2018. The Company is primarily engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets.
- APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients. The Company currently own and operate two manufacturing facilities at Bhavnagar and Ankleshwar in the Gujarat.
Popular Search
FAQs for Par Drugs & Chemicals Ltd Share Price History
What are the key events that typically impact Par Drugs & Chemicals Ltd's share price history?
Key events that impact Par Drugs & Chemicals Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Par Drugs & Chemicals Ltd's share price history?
Stock splits reduce the nominal price of Par Drugs & Chemicals Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Par Drugs & Chemicals Ltd?
Dividends can influence Par Drugs & Chemicals Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Par Drugs & Chemicals Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Par Drugs & Chemicals Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Par Drugs & Chemicals Ltd’s share price history?
To understand Par Drugs & Chemicals Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
